FDA 483 - Dr. Reddy’s Laboratories Limited - July 07, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Dr. Reddy's Laboratories Limited in Pydibhimavaram, India, from June 30 to July 7, 2022, revealed significant deficiencies. The firm failed to establish and follow adequate procedures to prevent microbiological contamination of sterile drug products, including issues with environmental monitoring. Additionally, the quality control unit did not fully adhere to written procedures, specifically regarding the investigation of particle and fiber defects found in media fill batches.
ID · da825a57-d71c-458f-b9ea-f8ff1569e3f3